J&J Defeats First Lawsuit on Tylenol's Link to Liver Damage
- Ruling comes in first case to go to trial over claims
- J&J faces about 220 similar suits in New Jersey, Philadelphia
This article is for subscribers only.
Johnson & Johnson defeated a lawsuit claiming it had improperly designed its Tylenol pain reliever, in the first case to go to trial over the link between the widely used over-the-counter drug and liver damage.
Jurors in New Jersey concluded that Regina Jackson, 55, who said she spent a week in the hospital after inadvertently overdosing on the pain medication, failed to prove her case. The jury ruled she couldn’t prove she had actually taken Extra Strength Tylenol, and didn’t rule on the merits of her claim the pain medication was defectively designed.